Close Menu

NEW YORK – PerkinElmer reported after the close of the market a 5 percent year-over-year increase in revenues for the third quarter, falling short of the consensus Wall Street estimate.

For the three months ended Sept. 29, the Waltham, Massachusetts-based firm said that revenues grew to $706.9 million, up from $674.3 million in Q3 2018. The analysts' average estimate was $715.9 million.

Organically revenues grew also at 5 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.